Skip to main content
Top
Published in: European Radiology 2/2011

01-02-2011 | Vascular-Interventional

High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: Comparison with contrast-enhanced MR angiography

Authors: Oliver K. Mohrs, Steffen E. Petersen, Martin C. Heidt, Thomas Schulze, Peter Schmitt, Sabine Bergemann, Hans-Ulrich Kauczor

Published in: European Radiology | Issue 2/2011

Login to get access

Abstract

Objective

To determine the diagnostic value of non-contrast-enhanced, 3D-high-resolution, ECG-gated, multi-step MR angiography (non-ceMRA) of the lower extremities using a modified turbo-spin-echo technique in comparison to 1.0-molar contrast-enhanced MR angiography (ceMRA) in patients with suspected peripheral vascular disease (PVD).

Methods

Fifty consecutive patients underwent non-ceMRA before ceMRA within the same session. We assessed examination time, image quality, localisation and severity of stenosis.

Results

Examination time was shorter for ceMRA (12 ± 4 min) compared with non-ceMRA (28 ± 6 min, p < 0.001). The image quality of the aorta-iliac, femoral and combined popliteal and lower leg arteries was inferior for non-ceMRA (2.8 ± 0.8/3.3 ± 0.8/3.3 ± 0.9) versus ceMRA (4.7 ± 0.8/4.8 ± 0.6/4.8 ± 0.7) on a 5-point scale with 5 for maximum quality (p < 0.01). CeMRA offered more assessable data sets than non-ceMRA (98% vs. 90%). For detecting stenosis >50% or occlusions of pelvic and femoral arteries using non-ceMRA the sensitivity, specificity, positive and negative predictive values were 94%, 86%, 67% and 98% and for popliteal and lower leg arteries 93%, 87%, 69% and 98%, respectively.

Conclusion

We demonstrated that 3D non-ceMRA represents a very promising technique in patients with lower extremities PVD and could be used as an alternative if gadolinium-based contrast agents cannot be administered.
Literature
1.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2006) ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation 113:e463–e654CrossRefPubMed Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2006) ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation 113:e463–e654CrossRefPubMed
2.
go back to reference Meaney JF (2003) Magnetic resonance angiography of the peripheral arteries: current status. Eur Radiol 13:836–852PubMed Meaney JF (2003) Magnetic resonance angiography of the peripheral arteries: current status. Eur Radiol 13:836–852PubMed
3.
go back to reference Tombach B, Heindel W (2002) Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 12:1550–1556CrossRefPubMed Tombach B, Heindel W (2002) Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 12:1550–1556CrossRefPubMed
4.
go back to reference Schaefer FK, Schaefer PJ, Altjohann C, Bourne M, Decobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, Oberholzer K, Pering C, Poeckler-Schoeninger C, Ruehm SG, Sachoran MR, Schulte-Altedorneburg G, Springer OS, Steiner P, Wall A, Winterer J, Tombach B (2007) A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. Eur J Radiol 61:315–323CrossRefPubMed Schaefer FK, Schaefer PJ, Altjohann C, Bourne M, Decobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, Oberholzer K, Pering C, Poeckler-Schoeninger C, Ruehm SG, Sachoran MR, Schulte-Altedorneburg G, Springer OS, Steiner P, Wall A, Winterer J, Tombach B (2007) A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. Eur J Radiol 61:315–323CrossRefPubMed
5.
go back to reference Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG (2001) 0.5M Gd chelate (Magnevist) versus 1.0M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 14:602–607CrossRefPubMed Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG (2001) 0.5M Gd chelate (Magnevist) versus 1.0M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 14:602–607CrossRefPubMed
6.
go back to reference Thomsen HS, Marckmann P, Logager VB (2007) Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 24:130–137CrossRef Thomsen HS, Marckmann P, Logager VB (2007) Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 24:130–137CrossRef
7.
go back to reference Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 110:738–743CrossRefPubMed Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 110:738–743CrossRefPubMed
8.
go back to reference Hentsch A, Aschauer MA, Balzer JO, Brossmann J, Busch HP, Davis K, Douek P, Ebner F, van Engelshoven JM, Gregor M, Kersting C, Knüsel PR, Leen E, Leiner T, Loewe C, McPherson S, Reimer P, Schäfer FK, Taupitz M, Thurnher SA, Tombach B, Wegener R, Weishaupt D, Meaney JF (2003) Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 13:2103–2114CrossRefPubMed Hentsch A, Aschauer MA, Balzer JO, Brossmann J, Busch HP, Davis K, Douek P, Ebner F, van Engelshoven JM, Gregor M, Kersting C, Knüsel PR, Leen E, Leiner T, Loewe C, McPherson S, Reimer P, Schäfer FK, Taupitz M, Thurnher SA, Tombach B, Wegener R, Weishaupt D, Meaney JF (2003) Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 13:2103–2114CrossRefPubMed
9.
go back to reference Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF (2000) Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 174:1127–1135PubMed Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF (2000) Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 174:1127–1135PubMed
10.
go back to reference High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed
11.
go back to reference Steffens JC, Link J, Müller-Hülsbeck S, Freund M, Brinkmann G, Heller M (1997) Cardiac-gated two-dimensional phase-contrast MR angiography of lower extremity occlusive disease. AJR Am J Roentgenol 169:749–754PubMed Steffens JC, Link J, Müller-Hülsbeck S, Freund M, Brinkmann G, Heller M (1997) Cardiac-gated two-dimensional phase-contrast MR angiography of lower extremity occlusive disease. AJR Am J Roentgenol 169:749–754PubMed
13.
go back to reference Lim RP, Hecht EM, Xu J, Babb JS, Oesingmann N, Wong S, Muhs BE, Gagne P, Lee VS (2008) 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 28:181–189CrossRefPubMed Lim RP, Hecht EM, Xu J, Babb JS, Oesingmann N, Wong S, Muhs BE, Gagne P, Lee VS (2008) 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 28:181–189CrossRefPubMed
14.
go back to reference Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J (2003) Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 227:890–896CrossRefPubMed Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J (2003) Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 227:890–896CrossRefPubMed
15.
go back to reference Huegli RW, Aschwanden M, Bongartz G, Jaeger K, Heidecker HG, Thalhammer C, Schulte AC, Hashagen C, Jacob AL, Bilecen D (2006) Intraarterial MR angiography and DSA in patients with peripheral arterial occlusive disease: prospective comparison. Radiology 239:901–908CrossRefPubMed Huegli RW, Aschwanden M, Bongartz G, Jaeger K, Heidecker HG, Thalhammer C, Schulte AC, Hashagen C, Jacob AL, Bilecen D (2006) Intraarterial MR angiography and DSA in patients with peripheral arterial occlusive disease: prospective comparison. Radiology 239:901–908CrossRefPubMed
16.
go back to reference Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM (2000) Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 217:105–114PubMed Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM (2000) Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 217:105–114PubMed
Metadata
Title
High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: Comparison with contrast-enhanced MR angiography
Authors
Oliver K. Mohrs
Steffen E. Petersen
Martin C. Heidt
Thomas Schulze
Peter Schmitt
Sabine Bergemann
Hans-Ulrich Kauczor
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
European Radiology / Issue 2/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1932-2

Other articles of this Issue 2/2011

European Radiology 2/2011 Go to the issue